Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nottingham University Hospitals NHS Trust | OTHER |
| Nottingham Hospitals Charity | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Posterior fossa tumours (PFT) account for 2/3 of childhood brain cancers. They can be highly malignant requiring combined chemotherapy and radiotherapy post-surgery for a >50% chance of cure. PFT frequently involve the cerebellum which is responsible for coordinating movement, balance, emotional control, and links closely to control of affect and executive function. PFT survivors show highly variable profiles for cognitive and sensorimotor functioning which are influenced strongly by the severity of the pre-diagnostic or post-surgical brain injury
State-of-the-art magnetic resonance imaging (MRI) scans can allow to measure a variety of different biological processes in the brain, and the investigators believe that some of these MRI measures (called MRI biomarkers) have the potential to improve our ability to understand and monitor consequences of the ablative brain surgery and complex mechanisms of motor skills recovery. Biomarkers are very important for the development of intervention because 1) they help understand the recuperation process and 2) they allow to effectively assess whether or not a treatment or intervention works.
Transcranial magnetic stimulation (TMS) is a powerful non-invasive neuro-modulatory intervention that has the potential to evaluate the integrity of the nervous tracts from the brain to the hand. It is a procedure that applies magnetic pulses on the surface of the scalp to reach underlying brain tissue. TMS has built a reputable status among neuro-rehabilitative research, and there is currently a major effort to translate the positive research findings into clinically useful therapeutic strategies.
This study is therefore an important first step towards understanding how potential MRI biomarkers and responses to TMS relate to motor symptoms in PFT young survivors. Once completed, this study will allow the investigators to select the most promising MRI biomarkers and TMS protocols to take forward into future treatment trials. The investigators aim to stimulate the recovery of coordination skills, help the development of targeted therapies, and consequently improve long-term quality of life in children and young people with history of brain tumour.
The proposed research intends to prove the feasibility of such brain stimulation and imaging and collect some preliminary measures
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Young PFT survivors |
| ||
| Age-matching controls |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Transcranial Magnetic Stimulation (TMS) | Other | With the TMS session we gather information about nerve fibres from the brain to the hand. It will last around 2 hours and 30 minutes. |
| Measure | Description | Time Frame |
|---|---|---|
| 5C-pilot Satisfaction Questionnaire | Participants rating their experience of MRI, TMS and motor assessment | 6 months |
| Completion rate of the sessions of TMS, MRI and motor tasks | Measure of quality of MRI images (participants motion) - Feasibility will be confirmed if 50% or more of these participants complete the TMS session | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Anatomical MRI metrics (PFT vs control) | Cerebellar volumetry and cerebellar parcellation - after surgery (mm3) | 1 year |
| fMRI metrics (PFT vs control) | Functional connectivity within sensorimotor network (activation map) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
4 participants with history of PFT (no history of seizure, no current cancer treatment) 6 healthy controls (no history of brain injury)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Caroline Blanchard | Contact | caroline.blanchard@nottingham.ac.uk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Queen's Medical Centre | Recruiting | Nottingham | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 28, 2026 | |
| Reset | May 20, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 28, 2026 | May 20, 2026 |
| ID | Term |
|---|---|
| D001932 | Brain Neoplasms |
| ID | Term |
|---|---|
| D016543 | Central Nervous System Neoplasms |
| D009423 | Nervous System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D050781 | Transcranial Magnetic Stimulation |
| D009682 | Magnetic Resonance Spectroscopy |
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D055909 | Magnetic Field Therapy |
| D013812 | Therapeutics |
| D013057 | Spectrum Analysis |
| D002623 | Chemistry Techniques, Analytical |
Not provided
Not provided
Not provided
Not provided
Not provided
| Magnetic Resonance Imaging (MRI) | Other | With the MRI scan we will gather information about the brain structure and function. This will last around 30 minutes. |
|
| Motor assessment | Other | The motor assessment includes a pegboard game, a "grab the alien nose" game and measure of your maximum grip force. In total it will last around 30 minutes. |
|
| Questionnaires | Other | Feasibility, tolerability of such intervention as well as quality of life of PFT survivors will be assessed thanks to questionnaires. |
|
| 1 year |
| Diffusion MRI metrics (PFT vs control) | Anatomical connectivity within sensorimotor network (tractography) | 1 year |
| Single-pulse TMS metrics (PFT vs control) | Resting motor threshold (Stimulus intensity expressed as a percentage of maximal stimulator output) | 1 year |
| Single-pulse TMS metrics (PFT vs control) | input-output curve | 1 year |
| Single-pulse TMS metrics (PFT vs control) | Silent period (ms) | 1 year |
| Single-pulse TMS metrics (PFT vs control) | Short-afferent inhibition | 1 year |
| Dual-pulse TMS metrics (PFT vs control) | Intracortical & long-latency inhibition and facilitation | 1 year |
| Dual-pulse TMS metrics (PFT vs control) | cerebellar-motor inhibition | 1 year |
| Motor performance (PFT vs control) - Reaching and grasping task | Kinematic parameters of movement | 1 year |
| Motor performance (PFT vs control) - Grooved pegboard | Score | 1 year |
| Motor performance (PFT vs control) - Grip force | Maximum force (N) | 1 year |
| Quality of life of PFT survivors: FACT-Peds-Br Questionnaire | FACT-Peds-Br Pediatric Questionnaire - For patients with Brain cancer | 6 months |
| D001927 |
| Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D008919 |
| Investigative Techniques |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |